Mouse aversion to isoflurane versus carbon dioxide gas

Add time:09/09/2019    Source:sciencedirect.com

Isoflurane and carbon dioxide (CO2) gas are used for rodent euthanasia. This study compared mouse aversion to isoflurane versus gradual-fill CO2 gas, and compared two methods of isoflurane delivery: vaporizer and drop. Mouse acclimation to a light–dark apparatus was used to create a light aversion test based on an unconditioned preference for dark versus light areas. Mice chose between remaining in a dark compartment with rising concentration of one of three treatments (20% gradual-fill chamber vol/min of CO2, n = 8; 5% isoflurane administered using a vaporizer set at 4 L/min oxygen flow, n = 9; or 5% liquid isoflurane dropped on gauze, n = 9), or escaping to a brightly lit compartment. On average (±S.E.) mice left the dark compartment after 29.2 ± 6.1 s in the isoflurane vaporizer treatment. Initial withdrawal time was lower for the CO2 treatment (P = 0.04), averaging 16.6 ± 2.8 s, and lower still for the isoflurane drop treatment (P < 0.001), averaging 2.9 ± 0.79 s. Five of nine mice became recumbent in the dark compartment when exposed to the isoflurane vaporizer treatment compared to only two of nine mice during the drop treatment (P = 0.3) and zero of eight mice during the CO2 treatment (P = 0.03). The isoflurane concentrations rose more quickly using the drop versus the vaporizer method, likely explaining the increased willingness of mice to be exposed to isoflurane administered via a vaporizer machine. Re-exposure to isoflurane with the vaporizer was more aversive than initial exposure; only two of nine mice stayed in the dark compartment until recumbency. These results support the recommendation that mice with no previous exposure to isoflurane should be euthanised using isoflurane administered by a vaporizer rather than CO2 gas, and suggest that the drop method (as applied in the current study) is not a suitable alternative.

We also recommend Trading Suppliers and Manufacturers of S-(+)-Isoflurane (cas 133098-05-2). Pls Click Website Link as below: cas 133098-05-2 suppliers

Prev:Journal ArticleEffects of a low concentration of isoflurane on contrast sensitivity in volunteers
Next:Validated liquid chromatographic–fluorescence method for the quantitation of Darifenacin (cas 133099-04-4) in mice plasma and its application to a pharmacokinetic study)